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Viral myocarditis presents with various symptoms, including fatal arrhythmia and cardiogenic shock, and may
develop chronic myocarditis and dilated cardiomyopathy in some patients. We report here a case of viral
myocarditis with liver dysfunction and pancreatitis. A 63-year-old man was admitted to our hospital with dyspnea.
The initial investigation showed pulmonary congestion, complete atrioventricular block, left ventricular dysfunction,
elevated serum troponin I, and elevated liver enzyme levels. He developed pancreatitis five days after admission.
Further investigation revealed a high antibody titer against coxsackievirus A4. The patient’s left ventricular
dysfunction, pancreatitis, and liver dysfunction had resolved by day 14, but his troponin I levels remained high, and
an endomyocardial biopsy showed T-lymphocyte infiltration of the myocardium, confirming acute myocarditis. The
patient underwent radical low anterior resection five weeks after admission for advanced rectal cancer found
incidentally. His serum troponin I and plasma brain natriuretic peptide levels normalized six months after admission.
He has now been followed-up for two years, and his left ventricular ejection fraction is stable.
This is the first report of an adult with myocarditis and pancreatitis attributed to coxsackievirus A4. Combined
myocarditis and pancreatitis arising from coxsackievirus infection is rare. This patient’s clinical course suggests that
changes in his immune response associated with his rectal cancer contributed to the amelioration of his viral
myocarditis.
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Myocarditis can present with a wide range of symptoms,
ranging from mild dyspnea to chest pain, cardiogenic
shock, and fatal arrhythmia. The main cause of myocarditis
is current or recent viral infection [1]. Enteroviruses,
specifically Coxsackievirus (CV) group B serotypes, have
traditionally been perceived as the predominant viral cause
[2], although adenoviruses, parvovirus B19, and human
herpesvirus 6 can also cause myocarditis [3-5].
The pathophysiological progression of viral myocarditis
includes three distinct phases [3]. The first phase is char-
acterized by a nonspecific innate immune response, caus-
ing virus-mediated cell lysis and the indirect destruction* Correspondence: akuzawa_nobuhiro@yahoo.co.jp
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stated.of cardiomyocytes [3,6]. During the second phase, a virus-
specific immune response, including CD8+ lymphocytes,
acts to eliminate the causative viruses, leading to heart
failure with the destruction of the infected cardiomyocytes
[3]. In the third phase, commonly a few weeks after infec-
tion, the destroyed cardiomyocytes are replaced by diffuse
fibrosis and progressive biventricular dilatation, resulting
in cardiac failure [1,3]. Approximately 50% of patients
with viral myocarditis develop chronic myocarditis, and
21% develop dilated cardiomyopathy (DCM) [7]. A longi-
tudinal study reported that the immune clearance of
viruses during or after the acute phase of myocarditis
correlates with improvements in the left ventricular ejec-
tion fraction (LVEF) [8]. In chronic myocarditis or DCM,
a persistent viral presence on endomyocardial biopsy
(EMB) specimens is associated with an increased mortality
rate [9]. However, viral genomic RNA and capsid proteinal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
Figure 1 Electrocardiography on admission. Electrocardiography
showed atrial fibrillation and an accelerated idioventricular rhythm
(62 beats/min), suggesting complete atrioventricular block.
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and 10% of cases, respectively [6]. Therefore, the relation-
ship between persistent viral infection and progression
from acute myocarditis to chronic irreversible cardiomy-
opathy is unclear.
We present here a rare case of CVA4 infection causing
acute myocarditis with concomitant pancreatitis and liver
dysfunction. The patient’s antibody titers against CVA4
were significantly elevated during the recovery period, and
a pathological examination of an EMB specimen showed
interstitial infiltration with CD3-positive lymphocytes,
despite a normal LVEF on left ventriculography, confirm-
ing acute myocarditis. His plasma brain natriuretic peptide
(BNP) and serum troponin I (TnI) levels remained ele-
vated. Five weeks after admission, the patient underwent
radical low anterior resection for advanced rectal cancer,
found by chance. Interestingly, his plasma BNP and serum
TnI levels returned to normal after surgery. The patient’s
clinical course suggests that the immune modulation asso-
ciated with his rectal cancer and surgery favorably affected
his acute myocarditis, preventing its progression to chronic
myocarditis or DCM.
Case report
A 63-year-old man was admitted to our hospital with a
three-day history of dyspnea and fatigue, which had
gradually increased until he experienced dyspnea and
fatigue at rest. He had taken amlodipine (5 mg/day) for
hypertension for the preceding five years, but had no
other remarkable past history or family history. He was
a nonsmoker and did not consume alcohol. Two weeks
previously, he had presented with flu-like symptoms,
including fever, sore throat, cough, and diarrhea, which
had completely resolved within a week.
On admission, his height was 168.3 cm, weight 65.0 kg,
and temperature 35.8°C. He was hypotensive, with a blood
pressure of 72/52 mmHg, but his heart rate was not ele-
vated (61 beats/min). A physical examination revealed
cyanosis of the lips, distended external jugular veins, preti-
bial edema in both legs, coarse crackles over the lower bi-
lateral lung fields, and mild enlargement of the liver. He
was obviously short of breath in room air, with blood O2
saturation of 93%, partial O2 pressure of 61.7 mmHg,
and partial CO2 pressure of 16.7 mmHg. A chest X-ray
showed mild pulmonary congestion and right pleural
effusion. Electrocardiography showed atrial fibrillation
and an accelerated idioventricular rhythm, suggesting
complete atrioventricular block (Figure 1). Transthoracic
echocardiography showed moderately impaired left
ventricular function with diffuse hypokinesis, but no
pericardial effusion or enlargement of the right heart.
The end-diastolic left ventricular dimension was 56 mm,
the end-systolic left ventricular dimension was 44 mm, and
LVEF calculated with the Teichholz formula was 42.9%.The interventricular septal thickness was 11 mm and the
posterior left ventricular wall thickness was 12 mm. The
diameter of the inferior vena cava was increased to 22 mm,
with no respiratory variation. Color Doppler echocardi-
ography showed mild tricuspid regurgitation and the es-
timated pressure gradient between the right atrium and
right ventricle was 25.1 mmHg. Laboratory tests showed
neutrophil-dominant leukocytosis, liver dysfunction, and
renal insufficiency (Table 1). His serum creatine phosphoki-
nase (CPK) MB isoenzyme, serum TnI, and plasma BNP
levels were markedly elevated. Abdominal ultrasonography
showed no abnormalities, other than moderately dilated
hepatic veins. Coronary angiography was not performed
because of the patient’s reduced renal function. The pa-
tient developed hemodynamically significant bradycardia
(28 beats/min) soon after admission, and a temporary
transvenous pacing wire was placed in the right ventricle.
The intravenous administration of dopamine (10 μg/
kg/min), unfractionated heparin (15,000 units/day),
and furosemide (20 mg/day) was begun on the day of
admission. The patient’s systolic blood pressure increased
to about 120 mmHg and stabilized. The low-dose intra-
venous administration of human atrial natriuretic peptide
(0.025 μg/kg/min) was begun on day 2. Nonsustained
monomorphic ventricular tachycardia lasting for about
1 min was observed several times on day 2, but had no
significant hemodynamic impact, and was effectively
treated with an intravenous bolus injection of amiodarone
(150 mg). On day 3, the patient’s atrioventricular con-
duction returned to normal and his daily urine output
increased to 3500 mL/day. On day 4, echocardiography
showed an improvement in LVEF to 55.2% and the
temporary pacing wire was removed. His serum CPK
levels peaked on day 4 at 3229 IU/L. On day 7, a chest
X-ray showed resolution of the right pleural effusion and
his serum creatinine level returned to normal (0.98 mg/dL).
Table 1 Laboratory findings on admission
Hematology Normal range
White blood cells* 13700/mm3 3300 – 9000/mm3
Red blood cells 467 × 104/mm3 430 – 570 × 104/mm3 (Male)
Hemoglobin 13.6 g/dl 13.5 – 17.5 g/dl (Male)
Hematocrit 41.3% 39.7 – 52.4% (Male)
Platelets 29.3 × 104/mm3 14.0 – 34.0 × 104/mm3
Differential white blood cell count
Segmented neutrophils* 70.0% 34.0 – 70.0%
Band cells, stab cells* 15.0% 1.0 – 7.0%
Eosinophils 1.0% 0 - 8.0%
Monocytes 5.0% 2.0 – 10.0%
Lymphocytes* 9.0% 18.0 – 49.0%
Biochemistry
Total protein* 6.2 g/dl 6.7 – 8.3 g/dl
Albumin* 3.4 g/dl 3.8 – 5.2 g/dl
AST* 2660 IU/l 10 – 40 IU/l
ALT* 2037 IU/l 5 – 45 IU/l
LDH* 3307 IU/l 120 – 240 IU/l
ALP* 793 IU/l 100 – 325 IU/l
γ-GTP* 197 IU/l 10 – 50 IU/l
Total bilirubin* 1.7 mg/dl 0.2 – 1.2 mg/dl
Direct bilirubin* 1.0 mg/dl 0 – 0.4 mg/dl
CPK* 978 IU/l 60 – 270 IU/l
CPK-MB* 231 ng/ml < 5.2 ng/ml
Blood urea nitrogen* 63.4 mg/dl 8.0 – 20.0 mg/dl
Creatinine* 3.01 mg/dl 0.61 - 1.04 mg/dl
Sodium 141 mEq/l 135 – 145 mEq/l
Potassium 3.8 mEq/l 3.5 – 5.0 mEq/l
Chloride 106 mEq/l 98 – 108 mEq/l
Calcium 8.4 mg/dl 8.4 – 10.4 mg/dl
Phosphorus 3.1 mg/dl 2.5 – 4.5 mg/dl
Glucose 99 mg/dl 70 – 109 mg/dl
C-reactive protein* 5.50 mg/dl < 0.30 mg/dl
BNP* 4806 pg/ml < 18.4 pg/ml






IgM anti-HAV Ab Negative Negative
Anti-HIV Ab Negative Negative
*These values are outside the normal ranges.
Abbreviations: AST aspartate aminotransferase, ALT alanine aminotransferase, LDH lactate dehydrogenase, ALP alkaline phosphatase, γ-GTP gamma-glutamyltranspeptidase,
CPK creatine phosphokinase, BNP brain natriuretic peptide, PT-INR international normalized ratio of prothrombin time, APTT activated partial thromboplastin time.
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Figure 3 Abdominal computed tomography (CT) on day 5.
Abdominal CT to investigate the cause of epigastric pain showed
localized swelling of the pancreatic body and tail, with no
cholelithiasis or tumor obstructing the common bile duct or
pancreatic duct, suggesting idiopathic pancreatitis.
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peptide was stopped, and the patient commenced a regimen
of oral losartan (25 mg/day), spironolactone (12.5 mg/day),
azosemide (30 mg/day), and warfarin (3.0 mg/day). Supple-
mental oxygen was no longer needed.
The patient’s liver dysfunction improved after admission.
His aspartate aminotransferase (AST) level peaked on day 2
(7752 IU/L) and his alanine aminotransferase (ALT) level
peaked on day 3 (5899 IU/L) (Figure 2). His biliary enzyme
levels and total bilirubin also increased, but not as much as
his AST and ALT levels. His prolonged prothrombin time
returned to normal on day 7. However, he complained
of epigastric pain on day 5, and laboratory tests showed
increased serum and urine amylase levels. Abdominal
computed tomography showed swelling of the pancreatic
body and tail, with increased retroperitoneal adipose-tissue
density, suggesting pancreatitis (Figure 3). No cholelithiasis
or tumor occluding the common bile duct or pancreatic
duct was observed, and his plasma immunoglobulin G4
level was normal. We administered intravenous gabexate
mesilate (600 mg/day) and ceftriaxone (2 g/day) from day 5
to day 12. The patient’s abdominal symptoms resolved after
a few days, and he recovered without complications. A
small amount of melena was observed on day 8, and a total
colonoscopy was scheduled. Both his liver dysfunction and
pancreatitis had resolved by day 14.
Cardiac catheterization on day 16 showed normal
pressure data and a normal cardiac index (3.2 L/min/m2).
Coronary angiography and left ventriculography showedFigure 2 Clinical course of the patient after admission. Levels
of serum aspartate aminotransferase (AST; diamonds), alanine
aminotransferase (ALT; squares), and creatinine phosphokinase
(CPK; triangles) were high. The AST level peaked on day 2, ALT on day 3,
and CPK on day 4. The levels of brain natriuretic peptide (BNP) and
troponin I (TnI) were highest at admission and subsequently decreased,
but did not return to normal. The gamma-glutamyl transpeptidase
(γ-GTP) level was moderately elevated during hospitalization. The
serum creatinine level returned to normal by day 7.no abnormalities and normal LVEF (64.2%). A patho-
logical examination of an EMB specimen of the left ven-
tricle showed necrotic cardiomyocytes adjacent to areas
with interstitial infiltration of CD3-positive lymphocytes
(Figure 4A–D), confirming acute myocarditis. The antibody
titer against CVA4 increased from 1:4 on day 1 to 1:256 on
day 15. On day 19, his plasma BNP level was 238 pg/mL
and his serum TnI level was 0.08 ng/mL, and both these
values continued to be slightly elevated thereafter.Figure 4 Histopathological examination of a biopsy specimen
from the left ventricle. Low-power view (× 100) (A) and high-power
view (× 400) (B) of the biopsy specimen obtained from the left ventricle,
stained with hematoxylin and eosin, showing lymphocytic infiltration
into the interstitium and mild necrosis of the myocardium.
Immunohistochemical staining with anti-CD3 (C) and anti-CD20
antibodies (D). CD3-positive lymphocytes were predominant.
Akuzawa et al. Virology Journal 2014, 11:3 Page 5 of 7
http://www.virologyj.com/content/11/1/3A colonoscopy on day 18 showed a protruding rectal
lesion above the level of the peritoneal reflection. The
plasma carcinoembryonic antigen level was 4.7 ng/mL
(normal: 0–4.9 ng/mL) and the cancer antigen 19–9 level
was 434.6 U/mL (normal: 0–36.9 U/mL). A pathological
examination of a biopsy specimen of the rectal lesion
showed a moderately differentiated tubular adenocarcin-
oma invading the muscularis propria. Transesophageal
echocardiography on day 27 showed no signs of left atrial
thrombus, and the administration of warfarin was stopped
in preparation for surgery. The patient was transferred
to the Department of Surgery on day 28, and underwent
a low anterior resection on day 35. The postoperative
diagnosis was stage II rectal cancer (T3N0M0, Union
for International Cancer Control Classification). His
postoperative recovery was uneventful, with no com-
plications such as heart failure or arrhythmia. He was
discharged on day 45. A histological examination of the
surgical specimen showed lymphovascular invasion, and
adjuvant chemotherapy with folinic acid, fluorouracil, and
oxaliplatin was commenced a month after discharge.
Interestingly, his plasma BNP level decreased to less
than half the preoperative value (78 pg/mL) and his serum
TnI level returned to normal (< 0.04 ng/mL) three weeks
after surgery. His plasma BNP level returned to normal
(18 pg/mL) four months after surgery. Oral medications
for heart failure were stopped five months after discharge.
The patient underwent a partial hepatectomy six months
after discharge for a solitary metastasis in the liver, but his
myocarditis did not recur. Adjuvant chemotherapy was
continued until 12 months after surgery. The patient has
now been followed-up for two years, with stable LVEF and
no recurrence of myocarditis or rectal cancer.
Discussion
Coxsackieviruses belong to the genus Enterovirus, in the
family Picornaviridae, and are important viral pathogens,
causing myocarditis and pancreatitis. CVs are subdivided
according to their pathogenicity in suckling mice aged less
than 48 h into CVA, which causes flaccid paralysis, and
CVB, which causes spastic paralysis [10-12]. There are 23
CVA serotypes and six CVB serotypes [12]. Although CVs
are known to cause myocarditis, most cases are attributed
to CVB serotypes [6]. CVA infection can cause viral
myocarditis, but it has a more benign course than CVB
myocarditis [12]. Serotypes A4 and A16 have been most
frequently implicated in the rare cases of CVA-associated
myocarditis reported [13]. Combined myocarditis and pan-
creatitis arising from CV infection is very rare, with only
three previously reported cases, which were all attributed to
CVB infection [14,15]. Ischemic pancreatitis was unlikely in
our patient because of the late disease onset (day 5) and
hemodynamic stability after admission. Moreover, although
we did not stop any medications, including diuretics,the patient’s pancreatitis improved spontaneously. There-
fore, it is more likely that his pancreatitis developed from
his CV infection. To our knowledge, this is the first re-
ported case of an adult patient with myocarditis and
pancreatitis attributable to CVA infection. It is unclear
why combined myocarditis and pancreatitis is uncommon
in CV-infected humans. In a mouse model, the viral titer
was higher in the pancreas than in the heart, liver, or
spleen during the early stage of CVB infection [16]. In
humans, CVB3 capsid protein VP1 was detected in both
the cardiomyocytes and islets of endocrine cells in patients
who died of acute CVB myocarditis [17]. These results
suggest that the rate of latent or asymptomatic pancreatitis
may be higher than previously thought in patients with
myocarditis attributable to CV infection.
The course of our patient’s myocarditis is interesting.
Although his LVEF on echocardiography improved soon
after admission and normalized on left ventriculography
by day 16, an EMB specimen on the same day still showed
prominent T-lymphocyte infiltration with a slightly elevated
serum TnI level. His serum TnI level had returned to nor-
mal three weeks after surgery, and his plasma BNP level
had also decreased at this time. This suggests that resection
of the rectal cancer may have resulted in the improvement
of his myocarditis and inhibited any progression to chronic
myocarditis or DCM. The patient’s normal LVEF during
the two-year follow-up supports this conjecture. The rela-
tionship between persistent viral infection and the estab-
lishment of chronic myocarditis is controversial. A recent
study reported that regulatory T cells (Tregs), which are
positive for CD4, CD25, and Foxp3, reduced viral titers and
suppress cardiac damage in CVB-infected mice [18]. Fur-
thermore, the myocardial Treg frequency was reduced dur-
ing the course of CVB3 myocarditis in BALB/c mice and
the adoptive transfer of Tregs resulted in the significant
amelioration of cardiac fibrosis [19]. Tregs maintain immu-
nohomeostasis and limit autoimmunity, but there may be
high levels of Tregs in the blood and tumor tissues of can-
cer patients, leading to the suppression of antitumor im-
munity [20]. The proportion of Tregs is significantly higher
in colon cancer patients than in healthy controls, and de-
creases significantly after the radical resection of the tumors
[21]. Increased Treg activity also suppresses CD8+ T-cell re-
sponses to specific antigens of various viruses [22]. The lim-
itations of our report include our inability to determine the
myocardial frequency or activity of Tregs before and after
surgery, but our findings suggest that the modulation of the
immune response associated with rectal cancer and surgery,
including a change in Treg activity, may have contributed
to the amelioration of myocarditis in our patient. More spe-
cifically, the increased Treg activity associated with rectal
cancer may have had an inhibitory effect on his cardiac fi-
brosis and CD8+ T-cell-associated myocardial damage dur-
ing the acute or subacute period of myocarditis, leading to
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of myocarditis per se could not be prevented. However, a
point of uncertainty persists because reduced Treg activity
after surgery might have exacerbated his myocarditis. Des-
pite this, the patient’s myocarditis improved. This suggests
that components other than Tregs were involved in the
improvement in his myocarditis, such as mesenchymal
stromal cells (MSCs), which have been identified in the
bone marrow and have unique immunoregulatory and
regeneration properties [23]. MSCs reduced myocardial
inflammation by reducing the expression of proinflam-
matory cytokines and inducing an increase in Tregs and
CD4+- and CD8+-T-cell apoptosis in CVB3-infected
mice [24]. However, it should be noted that no Treg or
MSC activity has yet been reported in patients with
chronic myocarditis or DCM. Although our patient’s
clinical course after surgery included the resolution of
his myocarditis, further research is required to clarify
the mechanisms involved.
Conclusion
We have presented a rare case of myocarditis, liver dys-
function, and pancreatitis arising from CVA4 infection
in a patient with undiagnosed advanced rectal cancer.
His clinical course was good and his elevated serum TnI
and plasma BNP levels returned to normal over four
months after the radical resection of his rectal cancer.
These features suggest that changes in the immune re-
sponse to myocarditis that were associated with the pa-
tient’s rectal cancer may have had a favorable effect on
his myocarditis, thereby preventing the progression of
acute myocarditis to chronic cardiomyopathy.
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